MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.
Summary
Digital pathology company with FDA-cleared prostate cancer detection and an expanding European regulatory footprint.
Finances
Not published (small company accounts)
Timeline
No verified timeline entries yet.